Table 1.
Demographic data, cognitive functions, plasma tau levels of the subjects
Group | Control (30) | MCI (20) | Early AD (10) |
---|---|---|---|
Age (years) | 64.4 ± 9.5 | 71.2 ± 9.7 | 69.3 ± 9.4 |
Gender female/male | 17/13 | 11/9 | 6/4 |
APOEε4 | 8 (1ε4/4) | 8 (1ε4/4) | 5 (3ε4/4) |
Education (years) | 13.1 ± 3.0 | 12.0± 3.1 | 7.6 ± 3.2*† |
CDR | 0 | .5 | .5/one with CDR1 |
MMSE | 28.8 ± 1.6 | 26.3 ± 2.7* | 22.7 ± 3.0*† |
Plasma tau level (pg/ml) | 15.6 ± 6.9 | 32.7 ± 5.8* | 53.9 ± 11.7*† |
Mean ± SD;
*: significant group difference between controls and MCI or early AD by using ANOVA at a significance level of P < 0.01;
†: significant group difference between MCI and Early AD at a significance level of P < 0.01; no significant between‐group difference in age, gender and APOEε4 distribution.